Sensitivity and breadth of detection of high-throughput sequencing for adventitious virus detection

Author:

Charlebois Robert L.,Sathiamoorthy Sarmitha,Logvinoff Carine,Gisonni-Lex Lucy,Mallet Laurent,Ng Siemon H. S.ORCID

Abstract

AbstractHigh-throughput sequencing (HTS) is capable of broad virus detection encompassing both known and unknown adventitious viruses in a variety of sample matrices. We describe the development of a general-purpose HTS-based method for the detection of adventitious viruses. Performance was evaluated using 16 viruses equivalent to well-characterized National Institutes of Health (NIH) virus stocks and another six viruses of interest. A viral vaccine crude harvest and a cell substrate matrix were spiked with 22 viruses. Specificity was demonstrated for all 22 viruses at the species level. Our method was capable of detecting and identifying adventitious viruses spiked at 104 genome copies per milliliter in a viral vaccine crude harvest and 0.01 viral genome copies spiked per cell in a cell substrate matrix. Moreover, 9 of the 11 NIH model viruses with published in vivo data were detected by HTS with an equivalent or better sensitivity (in a viral vaccine crude harvest). Our general-purpose HTS method is unbiased and highly sensitive for the detection of adventitious viruses, and has a large breadth of detection, which may obviate the need to perform in vivo testing.

Funder

Sanofi

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Infectious Diseases,Pharmacology,Immunology

Reference32 articles.

1. Folb, P. I. et al. A global perspective on vaccine safety and public health: the global advisory committee on vaccine safety. Am. J. Public Health 94, 1926–1931 (2004).

2. Barone, P. W. et al. Viral contamination in biologic manufacture and implications for emerging therapies. Nat. Biotechnol. 38, 563–572 (2020).

3. Petricciani, J., Sheets, R., Griffiths, E. & Knezevic, I. Adventitious agents in viral vaccines: lessons learned from 4 case studies. Biologicals 42, 223–236 (2014).

4. World Health Organization. Scientific Principles For Regulatory Risk Evaluation On Finding An Adventitious Agent In A Marketed Vaccine (Annex 2). WHO Expert Committee on Biological Standardization. https://www.who.int/biologicals/expert_committee/TRS_978_61st_report.pdf?ua=1 (2015). (Accessed May 2019).

5. EMEA, E. M. A. ICH Topic Q5A: Quality of Biotechnological Products: Viral Safety Evaluation of Biotechnology Products Derived from Cell Lines of Human or Animal Origin. ICH Harmonised Tripartite Guideline (2006).

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3